ABSTRACT: High-throughput nucleotide sequencing (often referred to as next-generation sequencing; NGS) is increasingly being chosen as a diagnostic tool for cases of expected but unresolved genetic origin. When explor-ing a higher number of genetic variants, there is a higher chance of detecting unsolicited findings. The consequen-tial increased need for decisions on disclosure of these unsolicited findings poses a challenge for the informed consent procedure. This article discusses the ethical and practical dilemmas encountered when contemplating in-formed consent for NGS in diagnostics from a multidis-ciplinary point of view. By exploring recent similar ex-periences with unsolicited findings in other settings, an attempt is made to descri...
Abstract: Next-generation sequencing (NGS) technologies allow for the generation of whole exome or w...
Background: Genetic testing in inherited disease has traditionally relied upon recognition of the pr...
Whole exome and whole genome sequencing are increasingly being offered to patients in the clinical s...
High-throughput nucleotide sequencing (often referred to as next-generation sequencing; NGS) is incr...
High-throughput nucleotide sequencing (often referred to as next-generation sequencing; NGS) is incr...
textabstractCancer patients participating in studies involving experimental or diagnostic next-gener...
Unsolicited findings (UFs) from diagnostic genetic testing are a subject of debate. The emerging con...
Unsolicited findings in genetic testing are disease causing variants which are unintentionally found...
Cancer patients participating in studies involving experimental or diagnostic next-generation sequen...
The wider availability of genomic sequencing, notably gene panels, in cancer care allows for persona...
Introduction: Next-generation sequencing (NGS) is transforming the conduct of genetic research and d...
While next-generation sequencing (NGS) has enormous potential to identify genetic causes of disease,...
While next-generation sequencing (NGS) has enormous potential to identify genetic causes of disease,...
Background While integrating genomic sequencing into clinical care carries clear medical benefits, i...
Any test that produces visual images or digital or genetic sequences will tend to produce incidental...
Abstract: Next-generation sequencing (NGS) technologies allow for the generation of whole exome or w...
Background: Genetic testing in inherited disease has traditionally relied upon recognition of the pr...
Whole exome and whole genome sequencing are increasingly being offered to patients in the clinical s...
High-throughput nucleotide sequencing (often referred to as next-generation sequencing; NGS) is incr...
High-throughput nucleotide sequencing (often referred to as next-generation sequencing; NGS) is incr...
textabstractCancer patients participating in studies involving experimental or diagnostic next-gener...
Unsolicited findings (UFs) from diagnostic genetic testing are a subject of debate. The emerging con...
Unsolicited findings in genetic testing are disease causing variants which are unintentionally found...
Cancer patients participating in studies involving experimental or diagnostic next-generation sequen...
The wider availability of genomic sequencing, notably gene panels, in cancer care allows for persona...
Introduction: Next-generation sequencing (NGS) is transforming the conduct of genetic research and d...
While next-generation sequencing (NGS) has enormous potential to identify genetic causes of disease,...
While next-generation sequencing (NGS) has enormous potential to identify genetic causes of disease,...
Background While integrating genomic sequencing into clinical care carries clear medical benefits, i...
Any test that produces visual images or digital or genetic sequences will tend to produce incidental...
Abstract: Next-generation sequencing (NGS) technologies allow for the generation of whole exome or w...
Background: Genetic testing in inherited disease has traditionally relied upon recognition of the pr...
Whole exome and whole genome sequencing are increasingly being offered to patients in the clinical s...